Douglas Fisher

Douglas Fisher

Corporate Officer/Principal presso SERA PROGNOSTICS, INC.

Patrimonio netto: 165 044 $ in data 29/02/2024

48 anni
Health Technology
Finance
Health Services

Profilo

Doug joined InterWest's healthcare team in 2009, focusing on biopharmaceutical, diagnostic and medical device investments, and portfolio company support.
He is a board member of Gynesonics and Indi Molecular and a former board member of Lycera, Obalon Therapeutics (NASDAQ: RSLS, acquired by ReShape Lifesciences) and PMV Pharma (NASDAQ GS: PMVP).
Doug is also actively involved in InterWest's investments in PMV Pharma (NASDAQ GS: PMVP), Potenza Therapeutics, Sera Prognostics (NASDAQ: SERA, where he serves as the Chief Business Officer), and Tizona Therapeutics.
Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments.
He was involved with several investments, including Pearl Therapeutics, Interlace Medical (Acquired by Hologic), and Stromedix (Acquired by Biogen Idec).
Prior to joining New Leaf, Doug was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area, consulting for leading pharmaceutical and biotech companies.
Previously, he worked for Centocor (a J&J operating company) in the Global Biologic Strategic Marketing Group.
Doug received an A.B.
in economics with honors and distinction, and a B.S.
in biology with distinction, from Stanford, where he graduated Phi Beta Kappa.
He has an M.D.
from the University of Pennsylvania School of Medicine and an M.B.A.
from Wharton, where he graduated with honors as a Siebel Scholar and Palmer Scholar.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
0.36%
14/02/2024 43 300 ( 0.36% ) 127 952 $ 29/02/2024
27/10/2023 5 572 ( 0.39% ) 37 093 $ 29/02/2024

Posizioni attive di Douglas Fisher

SocietàPosizioneInizio
SERA PROGNOSTICS, INC. Corporate Officer/Principal 29/04/2015
Founder -
Private Equity Investor 21/08/2020
Weavr Health Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Douglas Fisher

Precedenti posizioni note di Douglas Fisher

SocietàPosizioneFine
░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░ ░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Douglas Fisher

Formazione di Douglas Fisher

Stanford University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
Perelman School of Medicine Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Douglas Fisher

Relazioni

100 +

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
SERA PROGNOSTICS, INC.

Health Services

PMV PHARMACEUTICALS, INC.

Commercial Services

Aziende private20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Services

Health Services

Health Technology

Health Technology

Commercial Services

Finance

Finance

Health Technology

Precipio, Inc.

Electronic Technology

Finance

Finance

Weavr Health

Vedi le connessioni aziendali
  1. Borsa
  2. Insiders
  3. Douglas Fisher